名称:
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists
摘要:
The pharmacokinetic based optimisation of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 24 was found to be a highly potent and selective cannabinoid CB1 antagonist with high predicted human oral bioavailability. (C) 2011 Elsevier Ltd. All rights reserved.
DOI:
10.1016/j.bmcl.2011.02.019